Rad4Med

School on Radionuclide Productio
2024-05-27 08:00 - 2024-05-31 17:00 UTC | Arenberg Campus Heverlee, Celestijnenlaan, Heverlee, Belgium
In the context of PRISMAP, the European medical radionuclide programme, KU Leuven is organizing a School on Radionuclide Production the week of 27-31 May on the Arenberg Campus in Heverlee.
The school will cover topics ranging from cyclotron and reactor production of radionuclides, but also isotope separation, radiochemistry, logistics, etc. The idea is to gain an understanding of the complexity of the production and supply of radionuclides for medical applications.
More information about PRISMAP: https://www.prismap.eu/
Details about the school: https://www.prismap.eu/news/events-feed/summer-school-radionuclide-production/

9th ISMERAD
2024-04-26 08:00 - 17:00 UTC | NH Gent, Gent, 9000, Belgium
The 9th Symposium on Medical Radioisotopes intends to:
• Provide information on the perspectives of the world production of medical radioisotopes during the years to come;
• Discuss challenges of the transport and distribution processes including safety, security, transparency and prompt delivery;
• Present breakthroughs in radiopharmacy and nuclear medicine;
• Introduce new industrial and research initiatives.

Belgian EU Presidency Workshop: Securing Access to Radiopharmaceuticals for all European Patients
2024-02-28 08:00 - 17:00 UTC | Palais des Académies, Hertogstraat 1, Brussels, 1000, Belgium
During its presidency of the Council of the European Union, Belgium is striving towards a brighter future for radiopharmaceuticals. Therefore, the Directorate-General for Energy of the Federal Public Service Economy, SMEs, Self-Employed and Energy will organise a workshop on this topic at the Palais des Académies in Brussels on 28 of February 2024.
The one-day workshop is divided into four sessions, each focusing on a specific topic:
The first session will be devoted to “precision medicine in cancer therapy using radiopharmaceuticals”
The second to “the importance of doctor’s knowledge to guarantee patient’s quality of life: the patient’s perspective”
The third to “EU regulatory aspects”
The fourth session will consist of “securing the radiopharmaceutical supply chain and fostering the EU autonomy”
Each session will be made up of several subtopics presented by various speakers who are experts in both the nuclear medicine field and in European institutional and association circles.
More information

ENS Conference : Beating Cancer – Turning the tide with medical isotopes
2023-04-17 09:00 - 11:00 (Europe/Paris) | Radisson Blu Astrid Hotel, Antwerp, 7B Koningin Astridplein, Antwerp, Antwerp, 2018, Belgium
Every year 10 million patients in Europe benefit from nuclear medicine. In the past decade, research has made tremendous progress and medical isotopes are expected to become an even more vital tool in the treatment of many types of cancers.
In this session, we will learn about the use of medical isotopes for diagnosis and treatment. Our experts will give an update on increasingly effective therapeutics and the expected growth in medical nuclear procedures in line with these dynamic developments.
We will identify what is needed to establish a robust supply chain in the EU and to ensure that all patients receive the care they need when they need it.
Speakers:

Dr. Wouter Vogel, Antoni Van Leeuwenhoek Dutch Cancer Institute
Prof. Michel Koole, European Association of Nuclear Medicine (EANM)
Richard Zimmermann, MEDraysintell, and Sven Van den Berghe, Panthera

Moderator: Remigiusz Baranczyk, Euratom Supply Agency
You can attend the event on-site or via live streaming. It is free of charge, but we ask you for registering:
On-Site Participation: Please, select the On-Site Participation Ticket (max. 30 seats available)
Live Streaming: Please, register for a Live Streaming Ticket (starting from 09:00am)

PRISMAP training course | Translational research of radiopharmaceuticals
2023-03-20 09:00 - 2023-03-24 17:00 UTC | SCK CEN Mol, Boeretang 200, Mol, Antwerp, 2400, Belgium
This unique course touches upon the radiobiological, radiochemical and dosimetric aspects in the development of radiopharmaceuticals. The course is organized under the umbrella of the PRISMAP project (www.prismap.eu).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101008571 (PRISMAP).
Specific topics that will be covered are:

Radiobiological aspects of the use of radiopharmaceuticals: cancer cell inhibiting and cytotoxicity for normal cells;
Radiochemistry in the development of radiopharmaceuticals;
Dosimetric and microdosimetric aspects of the use of radiopharmaceuticals;
Examples of specific research studies in the development of radiopharmaceuticals.

Target audience:

PhD students as well as post-docs, junior scientists or technicians interested in radiopharmaceuticals for medical applications. The course can allow a maximum number of 20 participants.

Nuclear careers day 2023
2023-03-07 | Royal Academy for Science and the Arts of Belgium, Hertogstraat 1, Brussels, Belgium
The Nuclear Careers Day aims at introducing science and engineering students as well as professionals to available advanced education and training in nuclear themes, PhD and post-doc opportunities and to available jobs in nuclear industry, healthcare, governmental organizations and research centres.
During a walking lunch, participants can effectively network at the booths of participating companies, institutions and networks.
Technical visits are foreseen in the afternoon.
On March 6, one day before the in-person event, online one on one speed dating with key organisations will be possible to prepare for the in-person event.
